CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
People›
Joseph M. Limber
AddedFeb 14, 2024
UpdatedOct 19, 2026
Joseph M. Limber

Joseph M. Limber

Founder & CEO, Secura Bio

Joseph M. Limber's Career

Secura Bio

Secura Bio

$90MSan Diego, CA, US
Founder
Founder & CEO· C-Suite · Management

Leadership at Secura Bio

Joerg MoellerJoerg MoellerBoard Member
Charles R Romp "Chip"Charles R Romp "Chip"Board Member
Joe LimberJoe LimberBoard Member

Similar to Secura Bio

BioCurity PharmaceuticalsBioCurity PharmaceuticalsJupiter, FL, USOncology Drugsest. 2010BioCurity PharmaceuticalsJupiter, FL, US · est. 2010

BioCurity: A clinical-stage biopharmaceutical firm innovating to enhance radiation therapy for cancer patients.

Seed · $718.2k9
SequellaSequellaRockville, MD, USPharmaceuticalsest. 1997SequellaRockville, MD, US · est. 1997

Sequella Inc.: A US-based biopharmaceutical company innovating treatments for severe infectious diseases.

Public · $48.4M11
Baudax BioBaudax BioMalvern, PA, USPharmaceuticalsest. 2019Baudax BioMalvern, PA, US · est. 2019

Baudax Bio: A specialty pharma company innovating acute care solutions.

Public · $116.2M20
Apic BioApic BioCambridge, MA, USBiopharmaceuticalsest. 2017Apic BioCambridge, MA, US · est. 2017

Apic Bio: A dedicated biopharmaceutical firm innovating cures for genetic diseases.

Series A · $53.3M32

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

People Similar to Joseph M. Limber

Ellen SheetsEllen SheetsCo-Founder · SeQure DxNakul PasrichaNakul PasrichaCEO · PharmaSecureElyse BlazevichElyse BlazevichCo-Founder · Securisyn MedicalStephen HsuStephen HsuFounder · Prometheon PharmaAdi MohantyAdi MohantyCEO · Biora TherapeuticsCory LewisCory LewisCo-Founder · Incog Biopharma ServicesManesh ChandwaniManesh ChandwaniCEO · Superior Biologics